Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nicolaas Buijs"'
Autor:
Francesca Ruzzi, Arianna Palladini, Stine Clemmensen, Anette Strøbæk, Nicolaas Buijs, Tanja Domeyer, Jerzy Dorosz, Vladislav Soroka, Dagmara Grzadziela, Christina Jo Rasmussen, Ida Busch Nielsen, Max Soegaard, Maria Sofia Semprini, Laura Scalambra, Stefania Angelicola, Lorena Landuzzi, Pier-Luigi Lollini, Mette Thorn
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2654 (2022)
Vaccines are a promising therapeutic alternative to monoclonal antibodies against HER-2+ breast cancer. We present the preclinical activity of an ES2B-C001, a VLP-based vaccine being developed for human breast cancer therapy. FVB mice challenged with
Externí odkaz:
https://doaj.org/article/86f3d463db8d46898126b8d04acfafb3
Autor:
Francesca Ruzzi, Arianna Palladini, Stine Clemmensen, Annette Strobaek, Nicolaas Buijs, Tanja Domeyer, Jerzy Dorosz, Vladislav Soroka, Dagmara Grzadziela, Christina Jo Rasmussen, Ida Busch Nielsen, Max Soegaard, Maria Sofia Semprini, Laura Scalambra, Stefania Angelicola, Lorena Landuzzi, Pier-Luigi Lollini, Mette Thorn
Publikováno v:
Cancer Research. 83:687-687
ES2B-C001 is a virus-like particle (VLP) vaccine against human HER-2, developed for the therapy of breast cancer. We show here that ES2B-C001 effectively inhibits mammary carcinoma growth and metastasis in a transgenic mouse model expressing activate
Autor:
Jane Dannow Dyekjaer, Nicolaas Buijs, Katherina Garcia Vanegas, Ernesto Simon, Håvard Jenssen, Niels Bjerg Jensen, Michael Eichenberger, Beata Joanna Lehka, Michael Naesby, Walden E. Bjørn-Yoshimoto
Publikováno v:
Lehka, B J, Eichenberger, M, Bjorn-Yoshimoto, W E, Garcia Vanegas, K, Buijs, N A, Jensen, N B, Dyekaejr, J D, Jenssen, H, Simon, E & Naesby, M 2016, ' Improving heterologous production of phenylpropanoids in Saccharomyces cerevisiae by tackling an unwanted side reaction of Tsc13, an endogenous double-bond reductase ', FEMS Yeast Research, vol. 17, no. 1, fox004 . https://doi.org/10.1093/femsyr/fox004
FEMS Yeast Research
FEMS Yeast Research
Phenylpropanoids, such as flavonoids and stilbenoids, are of great commercial interest, and their production in Saccharomyces cerevisiae is a very promising strategy. However, to achieve commercially viable production, each step of the process must b